McKesson Corporation (MCK) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
MCK Revenue Growth
Revenue Breakdown (FY 2025)
MCK's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
MCK Revenue Analysis (2014–2025)
As of May 6, 2026, McKesson Corporation (MCK) generated trailing twelve-month (TTM) revenue of $397.96 billion, reflecting strong growth of +11.4% year-over-year. The most recent quarter (Q3 2026) recorded $106.16 billion in revenue, up 2.9% sequentially.
Looking at the longer-term picture, MCK's 5-year compound annual growth rate (CAGR) stands at +9.2%, indicating steady revenue expansion. The company achieved its highest annual revenue of $359.05 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows MCK's business is primarily driven by U.S. Pharmaceutical Segment (91%), International Segment (4%), and Medical-Surgical Solutions Segment (3%). With over half of revenue concentrated in U.S. Pharmaceutical Segment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including CAH (+12.8% YoY), HSIC (+4.0% YoY), and CVS (+7.8% YoY), MCK has underperformed the peer group in terms of revenue growth. Compare MCK vs CAH →
MCK Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| MCKCurrent | $398.0B | +11.4% | +9.2% | 1.2% | |
 CAH | $222.6B | +12.8% | +7.8% | 1.0% | |
 HSIC | $13.2B | +4.0% | +5.4% | 5.7% | |
 CVS | $402.1B | +7.8% | +8.4% | 2.6% | |
 CI | $275.0B | +8.8% | +11.4% | 3.3% | |
 OMI | $2.8B | -41.0% | -20.1% | 1.0% |
MCK Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $359.05B | +16.2% | $12.48B | 3.5% | $4.37B | 1.2% |
| 2024 | $308.95B | +11.7% | $12.20B | 3.9% | $3.93B | 1.3% |
| 2023 | $276.71B | +4.8% | $11.87B | 4.3% | $4.45B | 1.6% |
| 2022 | $263.97B | +10.8% | $12.65B | 4.8% | $2.72B | 1.0% |
| 2021 | $238.23B | +3.1% | $11.58B | 4.9% | $3.51B | 1.5% |
| 2020 | $231.05B | +7.8% | $11.40B | 4.9% | $3.01B | 1.3% |
| 2019 | $214.32B | +2.9% | $10.76B | 5.0% | $3.08B | 1.4% |
| 2018 | $208.36B | +4.9% | $10.39B | 5.0% | $2.92B | 1.4% |
| 2017 | $198.53B | +4.0% | $10.69B | 5.4% | $3.36B | 1.7% |
| 2016 | $190.88B | +6.6% | $10.94B | 5.7% | $3.85B | 2.0% |
Full MCK Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See MCK's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MCK Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MCK vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMCK — Frequently Asked Questions
Quick answers to the most common questions about buying MCK stock.
Is MCK's revenue growth accelerating or slowing?
MCK maintains +11.4% revenue growth, in line with its 5-year CAGR of +9.2%. TTM revenue stands at $398.0B. Growth rate remains consistent with historical average.
What is MCK's long-term revenue growth rate?
McKesson Corporation's 5-year revenue CAGR of +9.2% reflects the sustained expansion pattern. Current YoY growth of +11.4% is near this long-term average.
How is MCK's revenue distributed by segment?
MCK reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.